Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I/II Study of Human Induced Pluripotent Stem (iPS) Cell-derived Cardiomyocyte Spheroids (HS-001) in Patients With Severe Heart Failure, Secondary to Ischemic Heart Disease

NCT04945018 is registered in ClinicalTrials.gov with Heartseed Inc. as lead sponsor.

NCT NCT04945018
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04945018 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I/II Study of Human Induced Pluripotent Stem (iPS) Cell-derived Cardiomyocyte Spheroids (HS-001) in Patients With Severe Heart Failure, Secondary to Ischemic Heart Disease
Lead sponsor
Heartseed Inc.
Phase
Phase 1/2
Overall status
Active, not recruiting
Start date
April 19, 2022
Completion date
January 31, 2026
Enrollment
10 (estimated)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

heart failure, ischemic heart disease